Company overview
Basic information
Company name
Farmacijos investicijos, UAB
Company code
300022793
Registered address
Vilnius, Savanorių pr. 11E-11, LT-03116
Registration date
2004-05-03
Company age: 22 y. 5 mo.
Status
Under Liquidation
Contact information
Edit data
Phone
Presented as an image – cannot be copied
Presented as an image – cannot be copied
Email
Not disclosed
(personal)
Website
None
Indicators
Risk factors
Activity
Legal form
Private Limited Liability Company
NACE activity
Freight transport by road
Sector
Užsienio subjektų kontroliuojamos ne finansų bendrovės
Ownership form
Private foreign capital
UAB "Farmacijos investicijos"
Company code: 300022793
Address: Vilnius, Savanorių pr. 11E-11, LT-03116
Description
This description was generated by artificial intelligence.
Farmacijos investicijos, UAB (company code 300022793) is an operational private limited liability company registered on 3 May 2004. It operates as a private company controlled by foreign entities, with foreign natural and legal persons holding more than 50% of the authorised capital. The company is governed by a CEO only and is classified as a micro company. Its registered address is Vilnius, Savanoriu pr. 11E-11, LT-03116, in Vilnius city municipality, Vilnius County. The company’s activity is listed under EVRK code H.49.41.00, Freight transport by road.
The company’s share capital is EUR 2.9K. In 2025, revenue was EUR 19.0K, compared with EUR 24.0K in 2024 and EUR 12.5K in 2023. Net profit for 2025 was a loss of EUR 5.0K after a profit of EUR 1.8K in 2024 and a loss of EUR 7.4K in 2023. The 2025 profit margin was -26.3%, and revenue decreased by 20.8% year on year, while remaining above the 2023 level. At the end of 2025, equity stood at EUR 56.4K and total assets at EUR 59.0K.
Average employment was 3 in 2023, 2024 and 2025, and remained 3 so far in 2026. The average wage data is not provided.
The company’s share capital is EUR 2.9K. In 2025, revenue was EUR 19.0K, compared with EUR 24.0K in 2024 and EUR 12.5K in 2023. Net profit for 2025 was a loss of EUR 5.0K after a profit of EUR 1.8K in 2024 and a loss of EUR 7.4K in 2023. The 2025 profit margin was -26.3%, and revenue decreased by 20.8% year on year, while remaining above the 2023 level. At the end of 2025, equity stood at EUR 56.4K and total assets at EUR 59.0K.
Average employment was 3 in 2023, 2024 and 2025, and remained 3 so far in 2026. The average wage data is not provided.
Download a detailed company report
Make confident decisions with all the information about Farmacijos investicijos, UAB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.